companydata.dkcompanydata.dk
Back to company

Symbiotiq ApS: Financial statements 2023

CVR: 42741809

Symbiotiq ApS (CVR 42741809) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,458,107 and a net result of DKK 898,015. Equity amounted to DKK 1,460,686. The solvency ratio was 64.2%.

Gross Profit
1,458,107 kr.
Profit/Loss
898,015 kr.
Equity
1,460,686 kr.
Total Assets
2,274,885 kr.

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Symbiotiq ApS publishes interim reportJan 20, 2023

Symbiotiq ApS has published its interim report for the period September 29, 2021 – December 31, 2022.

About Symbiotiq ApS

Symbiotiq ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2021. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Mads Bonde. The company is owned by Mads Bonde. In 2025, the company reported a gross profit of DKK 1,352,873 and a net result of DKK 288,354 compared with DKK 585,824 the year before. Equity amounted to DKK 2,077,864.

Other financial years

20252024